Diagnosis: Oral Focal Mucinosis or Verruciform Xanthoma
This painless, flesh-colored, raised lesion on the oral mucosa present for three weeks is most likely a benign reactive lesion, with oral focal mucinosis (OFM) and verruciform xanthoma (VX) being the leading differential diagnoses, though clinical diagnosis is nearly impossible without histopathological examination.
Clinical Reasoning
The presentation described—painless, flesh-colored, raised, non-erythematous, and persistent for 3 weeks—strongly suggests a benign soft tissue lesion rather than an inflammatory or malignant process. The absence of pain, redness, and tenderness effectively rules out most infectious, traumatic, or inflammatory etiologies.
Most Likely Diagnoses
Oral Focal Mucinosis is a rare benign lesion that typically presents as a painless, firm, sessile or pedunculated nodular swelling, most commonly on the gingiva 1, 2, 3. The clinical presentation is non-specific and frequently mimics other reactive gingival lesions like irritation fibroma or epulis. OFM appears as a flesh-colored mass with elastic hardness and healthy-appearing mucosa 3. Critically, prediagnosis of OFM is almost impossible based on clinical features alone 2.
Verruciform Xanthoma presents as a pink, yellow, or grey raised plaque or papule with granular, papillary, or verrucous surface morphology 4. It commonly affects the masticatory mucosa and appears as an asymptomatic, well-demarcated lesion 5. Clinical diagnosis is achieved in only approximately 2% of cases because it mimics other verruco-papillary lesions 6.
Key Distinguishing Features to Assess
- Location: OFM most commonly affects gingiva; VX favors masticatory mucosa (gingiva, hard palate)
- Surface texture: Smooth/nodular suggests OFM; verrucous/papillary suggests VX
- Color: Flesh-colored/pink favors OFM; yellowish-white suggests VX
- Consistency: Firm/elastic hardness is common to both
Critical Management Algorithm
Immediate Action Required
Excisional biopsy is mandatory for definitive diagnosis, as clinical features alone cannot distinguish between benign reactive lesions and more serious pathology 2, 3.
Pre-Biopsy Evaluation
Before proceeding with biopsy, obtain:
- Complete blood count to exclude hematologic disorders
- Coagulation studies to rule out bleeding contraindications
- Fasting blood glucose (hyperglycemia predisposes to fungal infections that can mimic benign lesions) 7
When to Expedite Biopsy
Any oral lesion persisting beyond 2 weeks should be reevaluated and considered for biopsy 8. Given this lesion has been present for 3 weeks, biopsy is indicated now.
Histopathological Confirmation
- OFM: Characterized by focal myxoid degeneration with spindle-shaped stellate fibroblasts and abundant mucin in the stroma 1, 2
- VX: Pathognomonic accumulation of lipid-laden foamy macrophages (xanthoma cells) within connective tissue papillae, with papillary epithelial architecture 5, 6
Common Pitfalls to Avoid
Do not assume this is a simple fibroma or epulis based on clinical appearance alone—both OFM and VX are frequently misdiagnosed as these more common lesions 2, 3
Do not delay biopsy waiting for spontaneous resolution—benign-appearing lesions can occasionally represent early malignancy, and the 3-week duration already warrants tissue diagnosis
Do not perform superficial shave biopsy—excisional biopsy provides both diagnosis and treatment for these benign lesions 3
Consider patient age and risk factors: While these lesions can occur at any age, VX may be associated with chronic irritation or immunosuppression 5
Prognosis and Follow-up
Both OFM and VX have excellent prognosis following complete surgical excision, with minimal recurrence risk 1, 3, 5, 6. However, histopathological diagnosis is essential to confirm the benign nature and rule out malignancy, which can clinically mimic these lesions 4, 6.
Monitor the surgical site for healing and schedule follow-up at 2-4 weeks post-excision to ensure complete resolution and absence of recurrence.